Head-to-head · WeighScore
Auren Rx vs LVNG RX
The verdict
Auren Rx takes it — 72.9/100 to 62.5/100.
Auren Rx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Auren Rx charges the same $149 for semaglutide and tirzepatide, which removes the usual reason to start on the weaker molecule.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | Auren Rx | LVNG RX |
|---|---|---|
| WeighScore | 72.9/100 | 62.5/100 |
| Grade | C | C |
| Site position | #83 | #303 |
| Semaglutide | $149/mo (auto-refill; a single month with no commitment is $179) | $149/mo (starting dose, compounded) |
| Tirzepatide | $149/mo (auto-refill; a single month with no commitment is $179) | $249/mo (microdose tier, starting dose, compounded) |
| Coverage | All 50 states | Coverage not published |
| Brand-name access | Not confirmed | Not confirmed |
| Oral / sublingual | Not confirmed | Not confirmed |
Site position #83 · C
Strengths
- Semaglutide and tirzepatide cost the same, so the choice of molecule is clinical rather than budgetary
- A microdose lane is priced separately at $129 on auto-refill rather than folded into the standard figure
- Names its dispensing pharmacy, VialsRX, with a street address and a phone number in Houston, Texas
- Names a prescribing physician and practice, and publishes support hours of Monday to Friday, 9 AM to 6 PM Eastern
Where it loses points
- The $149 figure requires enrolling in auto-refill; a single month with no commitment is $179
- Two different medical groups are named for the same service — Wasef Health, PC on the contact page and FAQ, Beluga Health, P.A. in the telehealth consent
- Product pages advertise a free online visit while the Terms make the initial online visit and any laboratory testing the patient's responsibility
- The FAQ says all 50 states, the Terms say service is available only in certain states, and no list is published
- No compounding class is stated for VialsRX, so whether it operates under 503A or 503B is unknown
- NAD+ is priced at two different figures on the same site, which is not reassuring about the GLP-1 numbers
Site position #303 · C
Strengths
- One bundled price covers the provider visit, prescription, shipping and ongoing check-ins, with zero consultation charges
- States you are charged nothing if a provider does not approve you for treatment
- Promises no dose-change surcharges — 'the price we quote is the price you pay, period'
- Semaglutide from $149/mo is competitive against the wider compounded market
- Offers a lower-dose GLP-1 microdose program alongside standard semaglutide and tirzepatide
Where it loses points
- Displays a Trustpilot 'Rated Excellent 4.8 / 5' badge, but no Trustpilot profile exists for the domain or the brand
- Also claims '4.9 based on 300+ Google reviews'; no Google listing for the business could be located
- Its own homepage figures conflict — '10k+' members in the hero versus '1,743+ patients supported' in the counters below
- The actual plan price is confirmed only after provider review, and the three treatment pages publish no prices at all
- No compounding pharmacy, medical group or individual clinician is named anywhere on the site
Featured provider
CoreAge Rx
CoreAge Rx scores 89.5/100 (B+). CoreAge Rx advertises flat dose pricing for compounded injections, with no membership fee; its consultation-fee and refund deadlines deserve a close read before paying.
Commercial relationships affect this placement. The score comparison above is separate.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.